French Pharmaceutical Company Rigorously Audits Multiple Digital Validation Solutions Selects ValGenesis VLMS

Fremont, CA: A French pharmaceutical company chose ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitalize its corporate validation process.

ValGenesis expanded its footprint in France following months of rigorous QA audits and selection processes. The company, which specializes in neuroscience and rare diseases and sells its products in over 100 countries, used sophisticated evaluation criteria to match vendor capabilities with their stringent business requirements. ValGenesis VLMS emerged as the clear winner at the end of the process.

ValGenesis VLMS, which is delivered as a service, impressed the customer with its remote validation and efficient change and risk management capabilities, which enable new levels of collaboration and improve enterprise-wide visibility into the validation process.

Check Out : Business Management Review

Change control-driven validation activities are decreased from weeks to hours with ValGenesis VLMS, and the company gains faster access to detailed metrics that help lower costs and cycle time.

"France ranks fourth in pharmaceutical production within the EU, making this a very exciting time for us to work with the country's most trusted pharmaceutical company," remarks Narayan Raj, Chief Operating Officer at ValGenesis. "Our SaaS-based solution was rigorously tested and earned their trust to create fully automated and transparent corporate validation processes that are standardized, optimized and audit-ready. This frees them to do what they do best: developing breakthrough treatments for patients around the globe. We look forward to an exciting journey ahead with them," he concluded.